Acer Therapeutics Inc (ACER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
Operating Expenses | 5,192 | 5,363 | 11,166 | 8,177 | 8,700 |
Operating Income | -5,192 | -5,363 | -11,166 | -8,177 | -8,700 |
Other Income | 36 | 111 | 124 | 208 | 203 |
Pre-tax Income | -5,156 | -5,252 | -11,042 | -7,969 | -8,496 |
Net Income Continuous | -5,156 | -5,252 | -11,042 | -7,969 | -8,496 |
Net Income | $-5,156 | $-5,252 | $-11,042 | $-7,969 | $-8,496 |
EPS Basic Total Ops | -0.51 | -0.52 | -1.09 | -0.79 | -0.89 |
EPS Basic Continuous Ops | -0.51 | -0.52 | -1.09 | -0.79 | -0.88 |
EPS Diluted Total Ops | -0.51 | -0.52 | -1.09 | -0.79 | -0.89 |
EPS Diluted Continuous Ops | -0.51 | -0.52 | -1.09 | -0.79 | -0.88 |
EBITDA(a) | $-5,175 | $-5,349 | $-11,148 | $-8,167 | $-8,688 |